Japan Tobacco Inc. · TSE:2914
Japan Tobacco — Q1 FY2007 Earnings Presentation
13 slides from Japan Tobacco's earnings presentation, Aug 1, 2006
Slide 1: 2007 3 1
2007 3 1 1 2 3 4 5 6 7 8 9 2 1
Slide 2: Consolidated results summary
2007 2007 3 1 2006 3 2007 3 1 1 11,510 12,895 1,385 4,927 5,445 517 EBITDA 1,158 1,341 182 855 1,020 165 843 1,035 191 475 762 287 3 2007 2007 3 1 1 2006 6 2006 7 ~ JT PMI BAT JT PMI BAT 330 Parliament 350 Parliament 320 340 310 Premium 330 D-spec Marlboro Lucky Strike D-spec Marlboro Lucky Strike 3
Slide 3: Domestic tobacco market share and D-spec trends
2007 2007 3 1 2006 7 7 JT * JT * 100% 2003 90% 600 540 80% 495 479 507 508 485 500 481 70% 66.1% 65.5% 65.3% 65.2% 65.5% 433 422 60% 400 50% 300 40% 30% 200 20% 100 10% 0% 0 Q1 Q2 Q3 Q4 Q1 Q1 Q2 Q3 Q4 FY 3/2006 FY 3/2007 FY 3/2005 FY 3/2006 FY 3/2007 Mild Seven Seven Stars Caster Cabin Peace Pianiss
Slide 4: Segment EBITDA and pharmaceutical pipeline
2007 2007 3 1 2006 3 2007 3 1 1 2,977 3,387 409 EBITDA 803 1,010 206 596 815 219 1,065 1,190 125 EBITDA 248 259 10 195 185 10 JT EBITDA 243 249 7 2006 1-3 7 2007 2007 3 1 2006 7 31 JTT-130 Phase2 Phase1 JTT-705 JTT-305 Phase2 JTT-130 Phase2 Phase1 JTK-303 HIV JTT-552 JTT-302 Phase1 Phase1 2006 3 200
Slide 5: Full-year forecast
2007 2007 3 1 2006 3 2007 3 1 1 691 702 11 EBITDA 24 35 10 10 19 8 9 2007 2007 3 2006 4 28 2006 3 2007 3 46,376 47,700 1,323 EBITDA 4,333 4,090 243 3,069 2,700 369 2,978 2,670 308 2,015 1,790 225 ROE(%) 12.4 9.7 2.7 FCF 1,455 3,250 1,794 JT 1,894 1,780 114 7 1 1 10 5
Slide 6: Operating income forecast bridge
2007 3 1 2007 2007 3 1 2006 3 1 2,045 +263 +11 -162 +0 2007 3 1 2,157 1,900 2,000 2,100 2,200 2,300 2,400 12 6
Slide 7: EBITDA bridge
2007 2007 3 1 EBITDA 2006 3 1 803 +200 +11 +40 -28 -67 +50 2007 3 1 1,010 700 800 900 1,000 1,100 13 2007 2007 3 1 2006 3 1 * 988 +92 -29 -33 2007 3 1 1,018 920 940 960 980 1,000 1,020 1,040 1,060 1,080 1,100 * US GAAP 1,065 1,190 1,190 125 14 7
Slide 8: Pharmaceutical and food EBITDA bridges
2007 2007 3 1 EBITDA JT 243 249 +2.5% 2006 3 1 274 -31 243 +41 -26 -2 -5 2007 3 1 249 200 210 220 230 240 250 260 270 280 290 EBITDA 248 259 10 15 2007 2007 3 1 2006 3 1 136 -3 -15 2007 3 1 117 110 115 120 125 130 135 140 16 8
Slide 9: Segment EBITDA bridge
2007 2007 3 1 EBITDA 2006 3 1 8 -4 -4 -13 2007 3 1 12 15 10 5 0 5 10 17 2007 2007 3 1 2006 3 1 691 VM +5 +4 +2 +0 +6 -0 -7 2007 3 1 702 680 685 690 695 700 705 710 18 9
Slide 10: Net income bridges
2007 2007 3 1 2006 3 1 10 +2 +14 -2 -1 -4 2007 3 1 19 0 5 10 15 20 25 30 19 2007 2007 3 1 2006 3 2006 3 843 475 1 1 +165 +191 +26 +96 2007 3 2007 3 1,035 762 1 1 700 800 900 1,000 1,100 300 400 500 600 700 800 20 10
Slide 11: Supplementary financial data
2007 3 1 1. 5. 05 4-6 06 4-6 05 4-6 06 4-6 11,510 12,895 1,385 JT 83 83 - - 8,656 9,852 1,196 JT ) 73 73 10 09 4 6,004 6,394 389 JT ) 9 10 8 07 4 1,968 2,175 206 - 2 20 25 3 3,995 4,216 220 0 2 5 11 3 2,045 2,157 112 0 2 5 11 3 1,065 1,190 125 USGAAP 2002 3 JT 136 117 18 691 702 11 465 475 10 6. 225
Slide 12: Supplementary quarterly sales volume data
1 2 JT + 2005 4 + 2005 5 JTI JT + JTI 1. 1. 1mg 4-6 7-9 10-12 1-3 JT 1mg 2004 542 556 556 477 2,132 4-6 7-9 10-12 1-3 2005 505 485 481 422 1,894 2004 8.3 8.2 8.6 8.9 8.5 2006 540 2005 10.6 11.7 12.2 12.5 11.7 2005 4 2005 5 JTI 2006 12.4 4-6 7-9 10-12 1-3 2004 10.4 10.3 10.7 11.1 10.6 2005 11.3 11.7
Slide 13: 13
13